Brookstone Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,385
Closed -$340K 816
2021
Q4
$340K Buy
+1,385
New +$343K 0.01% 598
2021
Q3
Sell
-1,037
Closed -$249K 763
2021
Q2
$249K Buy
+1,037
New +$236K ﹤0.01% 631

Other funds holding LH

Brookstone Capital Management's LH Position: Q1 2022 in Review

Brookstone Capital Management sold out of Labcorp (LH) in Q1 2022, closing a stake of 1,385 shares — an estimated $340K sold.

Brookstone Capital Management first reported a position in LH in Q2 2021 and held it in 2 quarters. The position peaked at $340K in Q4 2021. 1,033 funds tracked by Wall St. Rank hold LH as of Q1 2022.

  • Brookstone Capital Management reported no remaining Labcorp position as of Q1 2022 after selling out during the quarter.
  • Brookstone Capital Management sold 1,385 Labcorp shares in Q1 2022, an estimated $340K.
  • Brookstone Capital Management first reported a position in Labcorp in Q2 2021 and held it in 2 quarters.
  • Brookstone Capital Management's Labcorp position peaked at $340K in Q4 2021.
  • 1,033 funds tracked by Wall St. Rank held Labcorp as of Q1 2022.

Based on Brookstone Capital Management's 13F filing for Q1 2022, filed 12 Apr 2022.